Concepedia

Jenni Nikkilä

JN

16

Publications

1.6K

Citations

14

H-Index

2007

Active since

Affiliations

University of Oulu(Current)

Oulu University Hospital

AstraZeneca (United Kingdom)

The University of Texas MD Anderson Cancer Center

Tampere University Hospital

Jenni Nikkilä is an author at University of Oulu specializing in medicine, genetics, and cancer research.

ORCID

Top concepts

Publications per year

2007–2022

16

Publications

16

A recurrent mutation in PALB2 in Finnish cancer families

Hannele Erkko, Bing Xia, Jenni Nikkilä et al. · Nature · 2007 · 456 citations

, , +6

AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity

Jacqueline H. L. Fok, Antonio Ramos‐Montoya, Mercedes Vázquez–Chantada et al. · Nature Communications · 2019 · 327 citations · Full text

Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper

Giuditta Illuzzi, Anna D. Staniszewska, Sonja J. Gill et al. · Clinical Cancer Research · 2022 · 157 citations · Full text

Penetrance Analysis of the <i>PALB2</i> c.1592delT Founder Mutation

Hannele Erkko, James G. Dowty, Jenni Nikkilä et al. · Clinical Cancer Research · 2008 · 101 citations

BRD4 facilitates replication stress-induced DNA damage response

Jingwen Zhang, Austin Dulak, Maureen M. Hattersley et al. · Oncogene · 2018 · 100 citations · Full text

, , +5

Rows per page

1–5 of 16